Inventor

Raju Mohan

Inventor

Encinitas, CA, US

Overview

1996–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 68 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds35%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%

A61KPreparations for medical, dental or toiletry purposes18%

C07CAcyclic or carbocyclic compounds3%

C07BGeneral methods of organic chemistry2%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%

B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%

C40BCombinatorial chemistry1%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%

Y10TTechnical subjects covered by former us classification1%

PatentTitleYear

11,034,657Liver X receptor (LXR) modulators2021 10,905,687Substituted piperazines as ROR-gamma modulators2021 10,793,577Fused bicyclic compounds for the treatment of disease2020 10,683,291Heterocyclic compounds for the treatment of disease2020 10,421,759Fused bicyclic compounds for the treatment of disease2019 10,246,419Liver X receptor (LXR) modulators2019 10,233,187Fused bicyclic compounds for the treatment of disease2019 10,167,294Fused bicyclic compounds for the treatment of disease2019 10,047,055Liver X receptor (LXR) modulators2018 9,981,913Liver X receptor (LXR) modulators2018 9,834,542LXR modulators2017 9,751,869'LXR modulators'2017 9,637,481'Liver X receptor (LXR) modulators for the treatment of dermal diseases, disorders and conditions'2017 9,000,022'Imidazole based LXR modulators'2015 8,987,318'Liver X receptor (LXR) modulators for the treatment of dermal diseases, disorders and conditions'2015 8,846,739'TGR5 agonists'2014 8,785,488'Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity'2014 8,703,805'Modulators of LXR'2014 8,642,640'1-phenylpyrrole derivatives'2014 8,618,154'LXR modulators'2013 8,569,352'Imidazole based LXR modulators'2013 8,524,704'Azepinoindole derivatives as pharmaceutical agents'2013 8,487,117'Atropisomers of (hydroxyalkyl) pyrrole derivatives'2013 8,455,489'Substituted pyrimidine compositions and methods of use'2013 8,367,667'Pyrrole derivatives as pharmaceutical agents'2013 8,163,771'11 Î²-HSD1 modulators'2012 8,026,237'Pyrrole derivatives as pharmaceutical agents'2011 8,013,001'Modulators of LXR'2011 8,008,325'Plasma carboxypeptidase B inhibitors'2011 7,998,986'Modulators of LXR'2011 7,998,995'LXR and FXR modulators'2011 7,977,489'Benzylthiazolone inhibitors of estrogen-related receptors (ERR)'2011 7,863,298'Bridged ring structures as pharmaceutical agents'2011 7,595,311'Azepinoindole derivatives as pharmaceutical agents'2009 7,528,173'Plasma carboxypeptidase B inhibitors'2009 7,482,366'Modulators of LXR'2009 7,265,131'Isoquinolinone derivatives and their use as therapeutic agents'2007 7,202,263'N-heterocyclic derivatives as NOS inhibitors'2007 7,199,146'Imidazolidinedione analogs useful as anticoagulants and antithrombotics'2007 7,176,207'Platelet adenosine diphosphate receptor antagonists'2007 7,084,142'Platelet adenosine diphosphate receptor antagonists'2006 7,056,923'Platelet adenosine diphosphate receptor antagonists'2006 7,053,112'Imidazolidinedione analogs useful as anticoagulants and antithrombotics'2006 7,026,323'Platelet adenosine diphosphate receptor antagonists'2006 6,995,156'Platelet adenosine diphosphate receptor antagonists'2006 6,982,259'N-heterocyclic derivatives as NOS inhibitors'2006 6,872,381'Radiopharmaceuticals for diagnosing Alzheimer\'s disease'2005 6,861,424'Platelet adenosine diphosphate receptor antagonists'2005 6,676,926'Radiopharmaceuticals for diagnosing Alzheimer\'s disease'2004 6,274,091'Apparatus and process for multiple chemical reactions'2001 6,242,454'Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants'2001 6,166,088'Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants'2000 6,071,912'Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants'2000 5,994,375'Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants'1999 5,888,830'Apparatus and process for multiple chemical reactions'1999 5,863,914'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'1999 5,859,005'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'1999 5,846,970'Bicyclic pyrimidine derivatives and their use as anti-coagulants'1998 5,846,972'Bicyclic pyrimidine derivatives and their use as anti-coagulants'1998 5,753,635'Purine derivatives and their use as anti-coagulants'1998 5,731,308'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'1998 5,731,311'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'1998 5,728,697'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'1998 5,726,198'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'1998 5,726,173'N.N-di (aryl) cyclic urea derivatives as anti-coagulants'1998 5,693,641'Bicyclic pyrimidine derivatives and their use as anti-coagulants'1997 5,612,363'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'1997 5,504,070'Inhibitors of the conversion of big endothelin to endothelin'1996

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1996–2001Patents assigned to BERLEX LAB (18)· patent assignee history

1997–2005Based in Moraga, CA, US· patent location history

2004–2007Patents assigned to SCHERING AG (12)· patent assignee history

2005–2021Based in Encinitas, CA, US· patent location history

2006Based in Encinitis, CA, US· patent location history

2007–2014Patents assigned to EXELIXIS INC (12)· patent assignee history

2011–2017Patents assigned to EXELIXIS PATENT CO LLC (10)· patent assignee history

2012–2014Patents assigned to MOHAN RAJU (11)· patent assignee history

2017–2018Based in Malvern, PA, US· patent location history

2019Based in Wayne, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BERLEX LAB	18	1996–2001
EXELIXIS INC	12	2007–2014
SCHERING AG	12	2004–2007
MOHAN RAJUself	11	2012–2014
EXELIXIS PATENT CO LLC	10	2011–2017

Locations

Location	Patents	Span
Encinitas, California, US	42	2005–2021
Moraga, California, US	19	1997–2005
Malvern, Pennsylvania, US	3	2017–2018
Wayne, Pennsylvania, US	1	2019
Encinitis, California, US	1	2006